Target intelligence / Profile preview

Small nuclear ribonucleoprotein polypeptide G pseudogene 9 (SNRPGP9)

Target
SNRPGP9
Molecular classification
Other (Pseudogene)
01

Overview

Small nuclear ribonucleoprotein polypeptide G pseudogene 9 (SNRPGP9) is classified as a pseudogene, specifically related to the parental SNRPG gene, which encodes a component of the small nuclear ribonucleoprotein complex involved in pre-mRNA splicing[5]. Pseudogenes are genomic elements that resemble protein-coding genes but typically lack the ability to produce functional proteins due to accumulated mutations or truncations[3][5]. Although once thought to be nonfunctional “junk” DNA, some pseudogenes—including other members—have been shown to participate in regulation of gene expression by producing noncoding RNAs that can affect their parent gene or other genes through mechanisms such as antisense interference or acting as decoys for regulatory microRNAs[1][3]. However, there is no evidence that SNRPGP9 itself produces a protein or acts as a direct therapeutic target. Most public genomic sources, such as GeneCards, classify SNRPGP9 as a noncoding, functionally inert pseudogene[5].

02

Mechanism of action

Not applicable (no drug interactions or therapeutic targeting data).

03

Biological functions

May contribute to regulation of expression of the parental gene (in this case, the SNRPG gene) through non-coding RNA mechanisms, such as acting as a microRNA decoy or through generation of antisense transcripts[1][3].Generally does not encode a functional protein.
04

Disease associations

No direct disease association is reported for SNRPGP9.Some pseudogenes affect the expression of genes involved in cancer and other diseases, but there is no evidence for SNRPGP9 specifically[1][3].
05

Safety considerations

None identified; not targeted therapeutically.

Beyond the preview

Go deeper on Small nuclear ribonucleoprotein polypeptide G pseudogene 9 (SNRPGP9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small nuclear ribonucleoprotein polypeptide G pseudogene 9 (SNRPGP9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call